BriaCell Therapeutics BCTXW Stock
BriaCell Therapeutics Price Chart
BriaCell Therapeutics BCTXW Financial and Trading Overview
| BriaCell Therapeutics stock price | 0.0009 USD |
| Previous Close | 0.0021 USD |
| Open | 0.06 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0006 - 0.0019 USD |
| 52 Week Range | 0.0006 - 0.0019 USD |
| Volume | 186.38K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.03 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BCTXW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.00016993958 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BriaCell Therapeutics Stock Price History
| Beta (5Y Monthly) | 2.03 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.0019 USD |
| 52 Week Low | 0.0006 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
BCTXW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 1.67M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -161.64% |
| Return on Equity (ttm) | -444.067% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30268288 USD |
| Net Income Avi to Common (ttm) | -28707256 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.18M USD |
| Total Cash Per Share (mrq) | 5.4 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.42 |
| Book Value Per Share (mrq) | 5.296 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -28920240 USD |
| Levered Free Cash Flow (ttm) | -18512680 USD |
Profile of BriaCell Therapeutics
| Country | United States |
| State | BC |
| City | West Vancouver |
| Address | Bellevue Centre |
| ZIP | V7T 2X1 |
| Phone | 604 921 1810 |
| Website | https://briacell.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Q&A For BriaCell Therapeutics Stock
What is a current BCTXW stock price?
BriaCell Therapeutics BCTXW stock price today per share is 0.0009 USD.
How to purchase BriaCell Therapeutics stock?
You can buy BCTXW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics?
The stock symbol or ticker of BriaCell Therapeutics is BCTXW.
How many shares does BriaCell Therapeutics have in circulation?
The max supply of BriaCell Therapeutics shares is 0.
What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics PE Ratio is now.
What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics EPS is 0 USD over the trailing 12 months.